Welcome to LookChem.com Sign In|Join Free

CAS

  • or

308243-58-5

Post Buying Request

308243-58-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

308243-58-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 308243-58-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,8,2,4 and 3 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 308243-58:
(8*3)+(7*0)+(6*8)+(5*2)+(4*4)+(3*3)+(2*5)+(1*8)=125
125 % 10 = 5
So 308243-58-5 is a valid CAS Registry Number.

308243-58-5Relevant articles and documents

Novel benzodiazepines derivatives as analgesic modulating for Transient receptor potential vanilloid 1

Liu, Yan,Liao, Chen,Zhou, Jiaqi,Liu, Chunxia,Li, Qifei,Jiang, Yue,Qian, Hai

, p. 4567 - 4573 (2018)

A new series of derivatives of 3-(7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanoic acid were designed and synthesized as analgesic modulating for Transient receptor potential vanilloid 1. They were investigated for TRPV1 antagonistic activity in vitro, analgesic activity and sedative activity in vivo and aqueous solubility. Preliminary studies identified 3-(7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-N,N-dimethylpropanamide(Compound 11), as a potent analgesic modulating for TRPV1 with potent activity and good aqueous solubility.

Identification and structure-activity studies of novel ultrashort-acting benzodiazepine receptor agonists

Stafford,, Jeffrey A.,Pacofsky,, Gregory J.,Cox, Richard F.,Cowan, Jill R.,Dorsey Jr., George F.,Gonzales, Stephen S.,Jung, David K.,Koszalka, George W.,McIntyre, Maggie S.,Tidwell, Jeffrey H.,Wiard, Robert P.,Feldman, Paul L.

, p. 3215 - 3218 (2007/10/03)

The synthesis and evaluation of novel ultrashort-acting benzodiazepine (USA BZD) agonists are described. A BZD scaffold was modified by incorporation of amino acids and derivatives. The propionate side chain of glutamic acid tethers an enzymatically labile functionality where the metabolite carboxylic acid displays markedly reduced BZD receptor affinity. The USA BZDs were characterized by full agonism profiles.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 308243-58-5